CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Cold Fusion on MSN
Breakthrough: Scientists reverse blindness [CRISPR technology]
CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Trump is guilty of mortgage ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Biotech startup CrisprBits uses CRISPR-based techniques to change the shape of diagnostics by decoding genetic sequencing ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
A collaborative study led by biomedical researchers Chris Lengner and M. Andrés Blanco at the School of Veterinary Medicine at the University of Pennsylvania has identified two genes that suppress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback